These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 2113793
1. MICs and MBCs of Win 57273 against Mycobacterium avium and M. tuberculosis. Heifets LB, Lindholm-Levy PJ. Antimicrob Agents Chemother; 1990 May; 34(5):770-4. PubMed ID: 2113793 [Abstract] [Full Text] [Related]
2. Bacteriostatic and bactericidal activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex. Heifets LB, Lindholm-Levy PJ. Tubercle; 1987 Dec; 68(4):267-76. PubMed ID: 3138801 [Abstract] [Full Text] [Related]
4. Preliminary study of the in vitro activity of irloxacin against mycobacteria. Casal M, Gutierrez J, Ruiz P, Moreno G. Chemotherapy; 1995 Dec; 41(3):204-7. PubMed ID: 7656667 [Abstract] [Full Text] [Related]
6. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis. Foroumadi A, Soltani F, Moshafi MH. Boll Chim Farm; 2002 Dec; 141(5):394-6. PubMed ID: 12481384 [Abstract] [Full Text] [Related]
10. Comparative antimycobacterial activities of the newly synthesized quinolone AM-1155, sparfloxacin, and ofloxacin. Tomioka H, Saito H, Sato K. Antimicrob Agents Chemother; 1993 Jun; 37(6):1259-63. PubMed ID: 8392307 [Abstract] [Full Text] [Related]
11. Bactericidal activity in vitro of various rifamycins against Mycobacterium avium and Mycobacterium tuberculosis. Heifets LB, Lindholm-Levy PJ, Flory MA. Am Rev Respir Dis; 1990 Mar; 141(3):626-30. PubMed ID: 2155555 [Abstract] [Full Text] [Related]
12. Comparative in-vitro activity of Bay y 3118, a new quinolone, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex. Sirgel FA, Venter A, Heilmann HD. J Antimicrob Chemother; 1995 Feb; 35(2):349-51. PubMed ID: 7759400 [No Abstract] [Full Text] [Related]
13. Comparison of antimycobacterial activity of grepafloxacin against Mycobacterium avium with that of levofloxacin: accumulation of grepafloxacin in human macrophages. Hirota M, Totsu T, Adachi F, Kamikawa K, Watanabe J, Kanegasaki S, Nakata K. J Infect Chemother; 2001 Mar; 7(1):16-21. PubMed ID: 11406752 [Abstract] [Full Text] [Related]
14. Antituberculosis agents. IX. In vitro antimycobacterial activity of N-(2-phenyl-2-oxoethyl) and N-[2-(4-fluorophenyl)-2-oxoethyl]ciprofloxacin derivatives against some drug-resistant strains of Mycobacterium tuberculosis and Mycobacterium avium isolates. Foroumadi A, Soltani F. Boll Chim Farm; 2003 Mar; 142(6):248-50. PubMed ID: 14606264 [Abstract] [Full Text] [Related]
16. In vitro activity of the new quinolone lomefloxacin against Mycobacterium tuberculosis. Piersimoni C, Morbiducci V, Bornigia S, De Sio G, Scalise G. Am Rev Respir Dis; 1992 Dec; 146(6):1445-7. PubMed ID: 1333738 [Abstract] [Full Text] [Related]
17. In vitro activity of PD 127,391, an enhanced-spectrum quinolone. Wise R, Ashby JP, Andrews JM. Antimicrob Agents Chemother; 1988 Aug; 32(8):1251-6. PubMed ID: 3142350 [Abstract] [Full Text] [Related]